Company patents

VERO Biotech Inc.

VERO Biotech Inc. surprisingly shows a strong and sustained focus on "Drug Delivery Devices," accounting for 84.6% of its portfolio, despite a significant decline of 53.8% in 2025 and a further 16.7% decline so far in 2026, suggesting a potential shift in the specific types of devices being patented. Concurrently, "Pharmaceutical Preparations" saw a remarkable 150.0% growth in 2024, indicating an emerging focus on the formulations themselves, even as its "Non-metallic Inorganic Compounds" patents have consistently declined, falling 40.0% so far in 2026.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

39 US filings (since 2023) · 6 categories · 3 themes

Patents

Showing 1-10 of 44

Page 1 of 5